No.

Publication Date

Citing Article

1

2026

Kun Yang, Bingqing Yang, Jiamin Chen, Lili Gao, Xiaoyi Han, Junke Hu, Liang Zhang, Xiangmei Chen, Qi Wang, Xingang Zhou, Ting Liu, Xuefei Duan, Lei Sun. Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid, BMC Gastroenterology. 2026;   https://doi.org/10.1186/s12876-026-04686-9

2

2026

Magdalena Rogalska, Paweł Rogalski, Aleksandra Andrzejuk, Agnieszka Błachnio-Zabielska, Piotr Zabielski, Robert Flisiak. Lipidome remodeling in primary biliary cholangitis, Lipids in Health and Disease. 2026;   https://doi.org/10.1186/s12944-026-02887-5

3

2025

Vasiliy I Reshetnyak, Igor V Maev. Bile acid therapy for primary biliary cholangitis: Pathogenetic validation, World Journal of Experimental Medicine. 2025; 15:   https://doi.org/10.5493/wjem.v15.i1.101771

4

2025

Hong-Li Liu, Xing Liu, Yi-Fan Hu, Xi-Xuan Wang, Yu Zhang, Li Wang, Sha-Sha Li, Yi-Jun Bao, Si-Wei Zheng, Qing-Fang Xiong, Yan-Dan Zhong, Du-Xian Liu, Ping Huang, Xiao-Ning Feng, Wen-Quan Zeng, Cai-Yun Zhang, Kai Zhang, Yong-Feng Yang. Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis, BMC Gastroenterology. 2025; 25: 667.  https://doi.org/10.1186/s12876-025-04280-5

5

2025

Vasiliy Ivanovich Reshetnyak, Elena Vladimirovna Vinnitskaya, Igor Veniaminovich Maev. Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology, World Journal of Gastrointestinal Pathophysiology. 2025; 16:   https://doi.org/10.4291/wjgp.v16.i2.107347

6

2025

Shima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto, Hideki Kobara. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets, Journal of Clinical Medicine. 2025; 14: 8503.  https://doi.org/10.3390/jcm14238503